Neutrophil Inhibitory Factor Selectively Inhibits the Endothelium-Driven Transmigration of EosinophilsIn Vitroand Airway Eosinophilia in OVA-Induced Allergic Lung Inflammation

Autor: Silvia Schnyder-Candrian, Muazzam Jacobs, René Moser, Bernhard Ryffel, Marc Le Bert, Lea Brault, Bruno Schnyder, Isabelle Maillet
Přispěvatelé: Immunologie et Neurogénétique Expérimentales et Moléculaires (INEM), Centre National de la Recherche Scientifique (CNRS)-Université d'Orléans (UO)
Rok vydání: 2012
Předmět:
Zdroj: Asian Pacific journal of allergy and immunology
Asian Pacific journal of allergy and immunology, Allergy and Immunology Society of Thailand, 2012, 2012, pp.1-10. ⟨10.1155/2012/245909⟩
Journal of Allergy
ISSN: 1687-9791
1687-9783
0125-877X
Popis: Leukocyte adhesion molecules are involved in cell recruitment in an allergic airway response and therefore provide a target for pharmaceutical intervention. Neutrophil inhibitory factor (NIF), derived from canine hookworm (Ancylostoma caninum), binds selectively and competes with the A-domain of CD11b for binding to ICAM-1. The effect of recombinant NIF was investigated. Intranasal administration of rNIF reduced pulmonary eosinophilic infiltration, goblet cell hyperplasia, and Th2cytokine production in OVA-sensitized mice.In vitro, transendothelial migration of human blood eosinophils across IL-4-activated umbilical vein endothelial cell (HUVEC) monolayers was inhibited by rNIF (IC50:4.6±2.6 nM; mean ± SEM), but not across TNF or IL-1-activated HUVEC monolayers. Treatment of eosinophils with rNIF together with mAb 60.1 directed against CD11b or mAb 107 directed against the metal ion-dependent adhesion site (MIDAS) of the CD11b A-domain resulted in no further inhibition of transendothelial migration suggesting shared functional epitopes. In contrast, rNIF increased the inhibitory effect of blocking mAbs against CD18, CD11a, and VLA-4. Together, we show that rNIF, a selective antagonist of the A-domain of CD11b, has a prominent inhibitory effect on eosinophil transendothelial migrationin vitro, which is congruent to thein vivoinhibition of OVA-induced allergic lung inflammation.
Databáze: OpenAIRE